Teva Pharmaceutical Industries
Open
$32.87
Prev. Close
$32.89
High
$33.00
Low
$32.82
Market Snapshot
$37.84B
24.2
-1.45
$16.54B
Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. The company employs 31,173 full-time employees The firm operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. The company employs 31,173 full-time employees The firm operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Recently from Cashu
Teva Launches AHZANTIVE Biosimilar for Retinal Conditions in European Market
Teva Pharmaceutical Industries (Ticker: TEVA) embarks on a significant advancement in its product offerings with the launch of AHZANTIVE, a novel biosimilar designed for the treatment of retinal condi…
Teva's IMPACT-TD Study Reveals Missed Diagnoses in Younger Tardive Dyskinesia Patients
Teva Pharmaceutical Industries (Ticker: TEVA) announces important findings from its IMPACT-TD Registry that spans three years, focusing on tardive dyskinesia (TD). This research is particularly releva…
Teva Pharmaceutical's IMPACT-TD Registry Targets Mental Health Disorders in Young Adults.
Teva Pharmaceutical Industries (Ticker: TEVA) demonstrates a commitment to addressing mental health disorders among young adults through its recent presentation at the American Psychiatric Association…
Teva Launches Online Platform for Schizophrenia Support Amid Strong Stock Performance
Teva Pharmaceutical Industries launches the Home Ground Schizophrenia Community, an online platform that offers crucial support and resources for individuals affected by schizophrenia and their caregi…